Irish Independent
Irish Independent
At least a dozen subjects with life-threatening diseases like cancer, and who are expected to live at least 9 months, will participate in the double-blind trial over the next year in Santa Cruz, said Brad Burge, spokesman for the Multidisciplinary Association for ...
California scientists test Ecstasy as anxiety-reducer for gravely ill Channel News Asia
Ecstasy therapy approved for trial in Marin County SFGate
all 28 news articles »
from @ Health and Medical News http://ift.tt/1At8pl5
via Health and Medical NewsHealth and Medical News Pfizer Inc has already had its takeover overtures rebuffed three times by rival AstraZeneca Plc, but investors in the U.S. drugmaker say it can tolerate a little more rejection before going hostile with the deal. AstraZeneca turned down a sweeten...
